Guangxi Liuzhou Pharm Co Ltd (603368) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Guangxi Liuzhou Pharm Co Ltd (603368) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.64 Million ≈ $6.68 Million USD) by net assets (CN¥8.14 Billion ≈ $1.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Guangxi Liuzhou Pharm Co Ltd for the company's overall valuation and market capitalisation.

Guangxi Liuzhou Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Guangxi Liuzhou Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guangxi Liuzhou Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangxi Liuzhou Pharm Co Ltd ranked by their cash flow conversion efficiency. Explore Guangxi Liuzhou Pharm Co Ltd (603368) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Plazza AG SW:PLAN	0.016x
Neurones PA:NRO	0.144x
WUS Printed Circuit Co Ltd TW:2316	-0.028x
Standard Lithium Ltd NYSE MKT:SLI	-0.016x
Hangzhou MDK Opto Electronic Corp. Ltd. A SHG:688079	0.015x
Chengdu XGimi Technology Co. Ltd. A SHG:688696	-0.021x
CureVac NV F:5CV	0.034x
Beijing Qianjing Landscape Co SHG:603778	0.347x

Annual Cash Flow Conversion Efficiency for Guangxi Liuzhou Pharm Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. View Guangxi Liuzhou Pharm Co Ltd (603368) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.94 Billion ≈ $1.16 Billion	CN¥838.51 Million ≈ $122.70 Million	0.106x	+25.55%
2023-12-31	CN¥7.06 Billion ≈ $1.03 Billion	CN¥594.41 Million ≈ $86.98 Million	0.084x	+5.77%
2022-12-31	CN¥6.37 Billion ≈ $931.45 Million	CN¥506.43 Million ≈ $74.11 Million	0.080x	+38.77%
2021-12-31	CN¥5.81 Billion ≈ $849.64 Million	CN¥332.88 Million ≈ $48.71 Million	0.057x	-53.04%
2020-12-31	CN¥5.44 Billion ≈ $796.71 Million	CN¥664.69 Million ≈ $97.26 Million	0.122x	+37.70%
2019-12-31	CN¥4.66 Billion ≈ $681.54 Million	CN¥412.91 Million ≈ $60.42 Million	0.089x	+1508.91%
2018-12-31	CN¥4.05 Billion ≈ $592.21 Million	CN¥22.30 Million ≈ $3.26 Million	0.006x	+105.91%
2017-12-31	CN¥3.57 Billion ≈ $522.19 Million	CN¥-332.59 Million ≈ $-48.67 Million	-0.093x	-378.42%
2016-12-31	CN¥3.24 Billion ≈ $473.78 Million	CN¥108.39 Million ≈ $15.86 Million	0.033x	+142.47%
2015-12-31	CN¥1.36 Billion ≈ $199.10 Million	CN¥-107.25 Million ≈ $-15.69 Million	-0.079x	+30.12%
2014-12-31	CN¥1.17 Billion ≈ $171.78 Million	CN¥-132.42 Million ≈ $-19.38 Million	-0.113x	-353.08%
2013-12-31	CN¥501.00 Million ≈ $73.31 Million	CN¥22.33 Million ≈ $3.27 Million	0.045x	-72.11%
2012-12-31	CN¥378.59 Million ≈ $55.40 Million	CN¥60.51 Million ≈ $8.85 Million	0.160x	-67.14%
2011-12-31	CN¥274.23 Million ≈ $40.13 Million	CN¥133.38 Million ≈ $19.52 Million	0.486x	--

About Guangxi Liuzhou Pharm Co Ltd

SHG:603368 China Medical Distribution

Market Cap

$885.82 Million

CN¥6.05 Billion CNY

Market Cap Rank

#9418 Global

#2352 in China

Share Price

CN¥15.24

Change (1 day)

-0.78%

52-Week Range

CN¥14.59 - CN¥20.31

All Time High

CN¥62.90